OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma
Takahide Nejo, Lin Wang, Kevin K. Leung, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Takahide Nejo, Lin Wang, Kevin K. Leung, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Darwin Kwok, Nicholas Stevers, Iñaki Etxeberría, et al.
Nature (2025)
Open Access | Times Cited: 2
Darwin Kwok, Nicholas Stevers, Iñaki Etxeberría, et al.
Nature (2025)
Open Access | Times Cited: 2
Engineered Antibodies as Cancer Radiotheranostics
Zhen-Ni Wei, Bingyu Li, Xuejun Wen, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 8
Zhen-Ni Wei, Bingyu Li, Xuejun Wen, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 8
Relevance of proteomics and metabolomics approaches to overview the tumorigenesis and better management of cancer
Pooja Singh, Yashika Walia, Shagun Gupta, et al.
3 Biotech (2025) Vol. 15, Iss. 3
Closed Access | Times Cited: 1
Pooja Singh, Yashika Walia, Shagun Gupta, et al.
3 Biotech (2025) Vol. 15, Iss. 3
Closed Access | Times Cited: 1
Molecular mechanisms of non-genetic aberrant peptide production in cancer
Demi Wernaart, Amos Fumagalli, Reuven Agami
Oncogene (2024) Vol. 43, Iss. 27, pp. 2053-2062
Closed Access | Times Cited: 5
Demi Wernaart, Amos Fumagalli, Reuven Agami
Oncogene (2024) Vol. 43, Iss. 27, pp. 2053-2062
Closed Access | Times Cited: 5
Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable surface proteoform in high-grade glioma
Priyanka Sehgal, Ammar S. Naqvi, Mary Higgins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Priyanka Sehgal, Ammar S. Naqvi, Mary Higgins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The emerging roles of aberrant alternative splicing in glioma
Reda Ben Mrid, Sara El Guendouzi, Marco Mineo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Reda Ben Mrid, Sara El Guendouzi, Marco Mineo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma
Darel Martinez Bedoya, Eliana Marinari, Suzel Davanture, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 12, pp. 1718-1735
Closed Access | Times Cited: 2
Darel Martinez Bedoya, Eliana Marinari, Suzel Davanture, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 12, pp. 1718-1735
Closed Access | Times Cited: 2
Targeting splicing for hematological malignancies therapy
Monika Szelest, Krzysztof Giannopoulos
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Monika Szelest, Krzysztof Giannopoulos
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
